38 results on '"Schetelig, Johannes"'
Search Results
2. Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
3. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
4. Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
5. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
6. Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
7. The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
8. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
9. The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT
10. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
11. Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
12. Potential of TCR sequencing in graft-versus-host disease
13. Klonale Hämatopoese – Bedeutung für die Zelltherapie
14. Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutions
15. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
16. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears
17. Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
18. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
19. Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study
20. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
21. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears
22. Clonal hematopoiesis and its emerging effects on cellular therapies
23. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS
24. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
25. Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
26. Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
27. Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
28. Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia
29. The clinical mutatome of core binding factor leukemia
30. Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas
31. Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
32. Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
33. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation
34. Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
35. Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)
36. Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome
37. Using efference copy and a forward internal model for adaptive biped walking
38. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.